BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

637 related articles for article (PubMed ID: 18653439)

  • 1. Review. Neurobiological mechanisms for opponent motivational processes in addiction.
    Koob GF; Le Moal M
    Philos Trans R Soc Lond B Biol Sci; 2008 Oct; 363(1507):3113-23. PubMed ID: 18653439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurobiological substrates for the dark side of compulsivity in addiction.
    Koob GF
    Neuropharmacology; 2009; 56 Suppl 1(Suppl 1):18-31. PubMed ID: 18725236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addiction as a stress surfeit disorder.
    Koob GF; Buck CL; Cohen A; Edwards S; Park PE; Schlosburg JE; Schmeichel B; Vendruscolo LF; Wade CL; Whitfield TW; George O
    Neuropharmacology; 2014 Jan; 76 Pt B(0 0):370-82. PubMed ID: 23747571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocircuitry of alcohol addiction: synthesis from animal models.
    Koob GF
    Handb Clin Neurol; 2014; 125():33-54. PubMed ID: 25307567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theoretical frameworks and mechanistic aspects of alcohol addiction: alcohol addiction as a reward deficit disorder.
    Koob GF
    Curr Top Behav Neurosci; 2013; 13():3-30. PubMed ID: 21744309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theoretical Frameworks and Mechanistic Aspects of Alcohol Addiction: Alcohol Addiction as a Reward Deficit/Stress Surfeit Disorder.
    Koob GF; Vendruscolo L
    Curr Top Behav Neurosci; 2023 Jul; ():. PubMed ID: 37421551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurobiology of Opioid Addiction: Opponent Process, Hyperkatifeia, and Negative Reinforcement.
    Koob GF
    Biol Psychiatry; 2020 Jan; 87(1):44-53. PubMed ID: 31400808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antireward, compulsivity, and addiction: seminal contributions of Dr. Athina Markou to motivational dysregulation in addiction.
    Koob GF
    Psychopharmacology (Berl); 2017 May; 234(9-10):1315-1332. PubMed ID: 28050629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addiction is a Reward Deficit and Stress Surfeit Disorder.
    Koob GF
    Front Psychiatry; 2013; 4():72. PubMed ID: 23914176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurobiology of addiction. Toward the development of new therapies.
    Koob GF
    Ann N Y Acad Sci; 2000; 909():170-85. PubMed ID: 10911930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hedonic Homeostatic Dysregulation as a Driver of Drug-Seeking Behavior.
    Koob GF
    Drug Discov Today Dis Models; 2008; 5(4):207-215. PubMed ID: 20054425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dark side of emotion: the addiction perspective.
    Koob GF
    Eur J Pharmacol; 2015 Apr; 753():73-87. PubMed ID: 25583178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroadaptive mechanisms of addiction: studies on the extended amygdala.
    Koob GF
    Eur Neuropsychopharmacol; 2003 Dec; 13(6):442-52. PubMed ID: 14636960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain stress systems in the amygdala and addiction.
    Koob GF
    Brain Res; 2009 Oct; 1293():61-75. PubMed ID: 19332030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcoholism: allostasis and beyond.
    Koob GF
    Alcohol Clin Exp Res; 2003 Feb; 27(2):232-43. PubMed ID: 12605072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addiction and the brain antireward system.
    Koob GF; Le Moal M
    Annu Rev Psychol; 2008; 59():29-53. PubMed ID: 18154498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of neuronal circuits in addiction: reward, antireward, and emotional memory.
    Koob GF
    Pharmacopsychiatry; 2009 May; 42 Suppl 1(Suppl 1):S32-41. PubMed ID: 19434554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neurobiology of addiction: a neuroadaptational view relevant for diagnosis.
    Koob GF
    Addiction; 2006 Sep; 101 Suppl 1():23-30. PubMed ID: 16930158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of corticotropin-releasing factor in drug addiction: potential for pharmacological intervention.
    Logrip ML; Koob GF; Zorrilla EP
    CNS Drugs; 2011 Apr; 25(4):271-87. PubMed ID: 21425881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticotropin releasing factor: a key role in the neurobiology of addiction.
    Zorrilla EP; Logrip ML; Koob GF
    Front Neuroendocrinol; 2014 Apr; 35(2):234-44. PubMed ID: 24456850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.